Vascular endothelial growth factor has been shown to stimulate the migration of endothelial cells, the formation of blood vessels in tumours (Ambler et al, 2003) and is associated with an adverse outcome of breast cancer patients (Gasparini, 2001). Here, VEGFA is linked to breast carcinoma.